Locally advanced rectal cancer or locally recurrent (without distant metastasis) rectal cancer
Conditions
Interventions
rectal cancer group :afterloading brachytherapy with the novel arc-shaped multi-channel rectal intracavitary applicator
Sponsors
Peking University Third Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Age > 18 years(based on the date of signing the informed consent form) 2. Patients with locally advanced rectal cancer or locally recurrent (without distant metastasis) rectal cancer who are suitable for afterloading brachytherapy treatment. 3. Patients who are able to be treated with rear-loading radiotherapy as determined by the investigator based on his/her medical history, physical examination, and vital signs 4. Agree to participate in this study and follow the requirements of this study
Exclusion criteria
Exclusion criteria: 1. Patients with severe cardiopulmonary insufficiency or other vital organ insufficiency. 2. Patients with severe bleeding tendency or coagulation disorders. 3. Patients with rectal perforation or other serious complications. 4. Patients judged by the investigator to be unsuitable to participate in this clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of adverse reactions; | — |
Secondary
| Measure | Time frame |
|---|---|
| ORR;PFS;OS;LRFS;HRQoL; | — |
Countries
China
Contacts
Public ContactWang Hao
Peking University Third Hospital
Outcome results
None listed